Healthcare >> CEO Interviews >> April 15, 2002
DR. SHALOM Z. HIRSCHMAN is President and CEO of Advanced Viral Research
Corp. After a 28-year affiliation with The Mount Sinai School of
Medicine and The Mount Sinai Hospital, Dr. Hirschman joined Advanced
Viral Research Corp. as President and CEO at the end of 1996. He has
been published in many peer-reviewed journals, including The New England
Journal of Medicine, Nature and Science. He founded one of New York
City's first and most active AIDS treatment centers at Mount Sinai. Dr.
Hirschman is a graduate of the Albert Einstein College of Medicine. He
was both an Intern and a Resident at the Massachusetts General Hospital,
Harvard Medical School. He then spent seven years doing basic molecular
research at the National Institutes of Health in Bethesda, Maryland. Dr.
Hirschman is a Fellow of the American Society of Infectious Diseases, a
member of the American Society for Clinical Investigation, the American
Association of Physicians, the American College of Clinical
Pharmacology, the Royal College of Hygiene and Tropical Medicine, the
American Biophysical Society, the American Society of Microbiology, and
the Society of General Virology, among others. Profile
TWST: Could we begin with a brief historical sketch of Advanced ViralResearch Corp. and a picture of what you are doing at the present time?
Dr. Hirschman: Advanced Viral Research Corp. is a